Article info
PDFOriginal research
Evaluating meaningful levels of financial toxicity in gynecologic cancers
- Correspondence to Dr Katharine McKinley Esselen, Department of Obstetrics and Gynecology, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA; kesselen{at}bidmc.harvard.edu
Citation
Evaluating meaningful levels of financial toxicity in gynecologic cancers
Publication history
- Received January 29, 2021
- Revision received March 26, 2021
- Accepted March 30, 2021
- First published April 15, 2021.
Online issue publication
April 24, 2022
Supplementary Data
This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© IGCS and ESGO 2021. No commercial re-use. See rights and permissions. Published by BMJ.